; and (2) in paragraph (10)(B)— (A) in clause (i), by striking A transfer and inserting Subject to clause (xiii), a transfer ; and (B) by adding at the end the following new clause: (xiii) In the case of a covered recipient described in paragraph (6)(A)(vi), a transfer of anything of value to the covered recipient by an applicable manufacturer described in paragraph (6)(C), unless the aggregate amount transferred to, requested by, or designated on behalf of the covered recipient by the applicable manufacturer during the calendar year exceeds $4,000. For calendar years after 2024, the dollar amount specified in the preceding sentence shall be increased by the same percentage as the percentage increase in the consumer price index for all urban consumers (all items; U.S. city average) for the 12-month period ending with June of the previous year. . (b) Treatment of certain payments or other transfers of value made by pharmaceutical trade associations Section 1128G(a)(1) of the Social Security Act (42 U.S.C. 1320a–7h(a)(1)) is amended by adding at the end the following new subparagraph: (C) Treatment of certain payments or other transfers of value by pharmaceutical trade associations For purposes of this section, the provisions that apply to an applicable manufacturer with respect to a payment or other transfer of value described in subparagraph (A) shall also apply to a pharmaceutical trade organization (as defined by the Secretary) but only with respect to a payment or other transfer of value described in such subparagraph provided to a covered recipient described in subsection (e)(6)(A)(vi) (or to an entity or individual at the request of or designated on behalf of a covered recipient described in such subsection). . (c) Effective date The amendments made by this section shall apply with respect to information required to be submitted under section 1128G of the Social Security Act ( 42 U.S.C. 1320a–7h ) on or after January 1, 2024.